Mass Tort News

In our previous blog, we provided you with a quick explainer about the Camp Lejeune Justice Act (“CLJA”) and how it became effective on August 10, 2022. If you have been following  the news, you probably have seen or heard about this horrific toxic water contamination at Camp Lejeune and […]

  Exactech, Inc., a medical device manufacturer headquartered in Gainesville, has recalled nearly 90,000 hip implant devices due to concerns of premature deterioration. The recall—which applies to the company’s MCS, Novation and Acumatch hip implant devices containing the company’s Connexion GXL liner—comes after two independent studies concluded that the synthetic […]

On February 17, 2022, Abbott Nutrition issued a voluntary recall affecting three of the company’s powder infant formula brands—Similac, Alimentum and EleCare. The recall applies specifically to powder formulas manufactured at the company’s facility in Sturgis, Michigan with an expiration date of April 1, 2022 or later. According to a […]

Almost three years after 3M’s resolution of a whistleblower lawsuit with the United States government, the judge overseeing lawsuits filed by individual servicemembers for hearing loss and tinnitus injuries has concluded the third trial over allegations that 3M and Aero Technologies defectively designed its Dual-Ended Combat Arms™ Earplugs, Version 2, […]

According to www.bloomberg.com, a recent court filing alleges that Sanofi, the French drug company that manufactures Zantac, the heartburn medication that was recalled in 2019, destroyed emails relating to the recall. The discovery that Zantac was contaminated with a carcinogen (cancer-causing agent) lead to the recall of the drug in […]

As reported by www.aboutlawsuits.com, plaintiffs in multiple Belviq cancer lawsuits seek consolidation of all claims, arguing that the number of complaints to be filed will dramatically increase. At least thirteen Belviq lawsuits have been filed in federal courts all over the country, all of which involve the same allegations and […]